| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0936-6555(05)80691-0 |
| P698 | PubMed publication ID | 8424911 |
| P2093 | author name string | W G Jones | |
| D W Newling | |||
| M J Ostrowski | |||
| M P Sokal | |||
| P2860 | cites work | A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867. | Q33431134 |
| 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data | Q36599799 | ||
| Biology and management of bladder cancer | Q37911018 | ||
| Chemotherapy of urothelial tract tumors | Q39657948 | ||
| Advanced transitional cell bladder cancer: a treatable disease | Q39701232 | ||
| Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse | Q43419722 | ||
| Cisplatin combination chemotherapy for elderly patients with urothelial tumours | Q43739870 | ||
| Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern | Q69401186 | ||
| M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience | Q69654530 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 25-29 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Clinical Oncology | Q1812651 |
| P1476 | title | A phase II study of epirubicin in advanced transitional cell bladder cancer. The Yorkshire Urological Cancer Research Group. | |
| P478 | volume | 5 |
Search more.